RxDoctor Payments Data

Franklin Cline

Physician Assistant · Sacramento, CANPI 1720020704

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $345,233 of the $458,372 with a category attached, or 75.3%. Johnson & Johnson accounts for 97.1% of it on its own, with 24 other manufacturers making up the rest. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$458,372in general payments, 2019–2025

Across 678 payments — averaging $676.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$445K
  • Janssen Scientific Affairs, LLC$9K
  • Otsuka America Pharmaceutical, Inc.$2K
  • AbbVie$380
  • Amgen$279
  • Sanofi$229
  • plus $2K from 19 others

What the payments were for

  • Consulting fees$8,3172%
  • Speaking & faculty fees$345,23375%
  • Travel & lodging$89,05919%
  • Food & beverage$15,6843%
  • Education$790%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$458,372 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide14$11,330
Aripiprazole18$549
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine17$529
Atenolol11$112
Hydrochlorothiazide11$14

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$70$11,33014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →